secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-09-09T23:59:59+00:00
Accession:  0001104659-25-088663
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics replaces Interim CEO; appoints Jason D. Sawyer
------------------------------------------------------------------

- Richard Joel Paolone terminated as Interim CEO and Chairman, effective Sept 3, 2025, without cause.
- Paolone remains as director; consulting agreement terminated with payment in lieu of notice.
- Jason D. Sawyer appointed Interim CEO effective Sept 4, 2025; continues as director.
- Sawyer has 32-year investment background; currently Head of Finance & M&A at Quantum BioPharma.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925088663/0001104659-25-088663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925088663/tm2525441-1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-088663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer